CellsBin® is a precision biotech company pioneering the future of rare-cell biology. Our mission is to unlock the diagnostic and therapeutic potential of ultra-rare cells in the blood — such as circulating tumor cells, fetal cells, and immune effectors — using an integrated platform of AI, nanophotonics, and microfluidics.